{"id":30138,"date":"2012-08-28T22:28:29","date_gmt":"2012-08-29T02:28:29","guid":{"rendered":"http:\/\/countingpips.com\/fx\/?p=30138"},"modified":"2012-08-28T22:28:30","modified_gmt":"2012-08-29T02:28:30","slug":"video-analyst-moves-gild-ir","status":"publish","type":"post","link":"https:\/\/www.investmacro.com\/fx\/2012\/08\/28\/video-analyst-moves-gild-ir\/","title":{"rendered":"VIDEO: Analyst Moves: GILD, IR"},"content":{"rendered":"<p><div id=\"grabDiv1767162\"><object id=\"GrabPlayer1767162\" width=\"542\" height=\"304\" type=\"application\/x-shockwave-flash\" align=\"middle\" data=\"http:\/\/player.grabnetworks.com\/swf\/GrabOSMFPlayer.swf?id=1767162&#038;content=v7e1479079795282d5f82f6680db1334504eb5d2c&#038;tgt=grabnetworks\"><param name=\"quality\" value=\"high\"\/><param name=\"allowScriptAccess\" value=\"always\"\/><param name=\"allowFullScreen\" value=\"true\"\/><param name=\"menu\" value=\"false\"\/><param name=\"wmode\" value=\"transparent\"\/><param name=\"movie\" value=\"http:\/\/player.grabnetworks.com\/swf\/GrabOSMFPlayer.swf?id=1767162&#038;content=v7e1479079795282d5f82f6680db1334504eb5d2c&#038;tgt=grabnetworks\"\/><\/object><\/p>\n<div id=\"overlay-adzone\" style=\"overflow:hidden; position:relative\"><\/div>\n<\/div>\n<p>Gilead (GILD) had its estimates and price target increased by Jefferies (JEF) after the approval of the stribild quad pill, as well as higher pricing announced for the future. A $55 price target was set with a hold rating.<\/p>\n<p><img src='http:\/\/images.grab-media.com\/market_news\/2012\/08\/28\/ID201208UPGRADES082812_thumb.jpg' \/><\/p>\n<p><!--post_img[http:\/\/images.grab-media.com\/market_news\/2012\/08\/28\/ID201208UPGRADES082812_preview.jpg]--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gilead (GILD) had its estimates and price target increased by Jefferies (JEF) after the approval of the stribild quad pill, as well as higher pricing announced for the future. A $55 price target was set with a hold rating.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-30138","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts\/30138","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/comments?post=30138"}],"version-history":[{"count":0,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts\/30138\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/media?parent=30138"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/categories?post=30138"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/tags?post=30138"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}